Prostate Cancer Nuclear Medicine Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00009519
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 180
Buy Now

Prostate Cancer Nuclear Medicine Diagnostics Market Scope 2031

Buy Now

Prostate Cancer Nuclear Medicine Diagnostics Market Report Prostate Cancer Nuclear Medicine Diagnostics Market Size and Share Prostate Cancer Nuclear Medicine Diagnostics Market Scope and Analysis

Prostate Cancer Nuclear Medicine Diagnostics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 720.12 Million
Market Size by 2028 US$ 1,315.66 Million
Global CAGR (2022 - 2028) 10.6%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Type
  • PET and SPECT
By PET Product
  • F-18
  • C-11
  • Ga68-PSMA
By End User
  • Hospitals
  • Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Blue Earth Diagnostics Limited
  • ImaginAB
  • Curium
  • Jubilant Radiopharma
  • NCM USA LLC
  • ABX Advanced Biochemical Compounds GmbH
  • Telix Pharmaceuticals Ltd
  • Novartis AG
  • Theragonostics